Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Conno

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Can somatostatin be administered in association with morphine in advanced cancer patients with pain?C Ripamonti, F De Conno, R Boffi, et al.
Tumori|October 31, 1985
The importance of a home care program for patients with advanced cancer painV Ventafridda, M Tamburini, S Selmi, et al.
Arzneimittel-Forschung|January 1, 1983
Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocineV Ventafridda, F De Conno, G Guarise, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1991
Frequency of suicide by cancer patients at the National Cancer Institute of Milan over 1986-90A Filiberti, C Ripamonti, L Saita, et al.
Cancer|February 15, 1987
A validation study of the WHO method for cancer pain reliefV Ventafridda, M Tamburini, A Caraceni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Unendurable symptoms as prognostic indicators of impending death in terminal cancer patientsV Ventafridda, C Ripamonti, M Tamburini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Management of bowel obstruction in advanced and terminal cancer patientsC Ripamonti, F De Conno, V Ventafridda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Leucocyte-lymphocyte ratio as prognostic indicator of survival in cachectic cancer patientsV Ventafridda, F De Conno, L Saita, et al.
The Hospice Journal|January 1, 1987
A new model of continuing care for advanced cancer pain treatmentV Ventafridda, S Selmi, G Di Mola, et al.
Tumori|July 1, 1996
Continuous subcutaneous infusion of ketorolac in cancer neuropathic pain unresponsive to opioid and adjuvant drugs. A case reportC Ripamonti, C Ticozzi, E Zecca, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Can somatostatin be administered in association with morphine in advanced cancer patients with pain?C Ripamonti, F De Conno, R Boffi, et al.
Tumori|October 31, 1985
The importance of a home care program for patients with advanced cancer painV Ventafridda, M Tamburini, S Selmi, et al.
Arzneimittel-Forschung|January 1, 1983
Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocineV Ventafridda, F De Conno, G Guarise, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1991
Frequency of suicide by cancer patients at the National Cancer Institute of Milan over 1986-90A Filiberti, C Ripamonti, L Saita, et al.
Cancer|February 15, 1987
A validation study of the WHO method for cancer pain reliefV Ventafridda, M Tamburini, A Caraceni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Unendurable symptoms as prognostic indicators of impending death in terminal cancer patientsV Ventafridda, C Ripamonti, M Tamburini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Management of bowel obstruction in advanced and terminal cancer patientsC Ripamonti, F De Conno, V Ventafridda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Leucocyte-lymphocyte ratio as prognostic indicator of survival in cachectic cancer patientsV Ventafridda, F De Conno, L Saita, et al.
The Hospice Journal|January 1, 1987
A new model of continuing care for advanced cancer pain treatmentV Ventafridda, S Selmi, G Di Mola, et al.
Tumori|July 1, 1996
Continuous subcutaneous infusion of ketorolac in cancer neuropathic pain unresponsive to opioid and adjuvant drugs. A case reportC Ripamonti, C Ticozzi, E Zecca, et al.
Pageof 11